Home
Home
Cancer

Legacy Heritage Clinical Research Institute at Rambam

"My generation had to establish the oncology service – consultations, chemotherapy, radiation oncology, state-of-the-art equipment, multidisciplinary tumor boards. Now that these foundations have been laid, the challenge of the next generation is to nurture people here who, in addition to their clinical excellence, will go from the bedside to the lab and back again."

Prof. Abraham Kuten, Director, Division of Oncology, RHCC

Today's oncologists speak of cancer in the plural because even a single category of this protean, recalcitrant disease – breast cancer, for example – is now understood not only to differ in appearance among individual patients but also to differ at the cellular and molecular level.

Next-generation clinical cancer research at Rambam will seek:

» To discover hereditary syndromes that predispose to cancer in global populations

»To identify risk factors and institute preventive measures

» Using a cancer's molecular signature, to predict which patients will benefit from particular, existing drugs

» To deliver personalized, targeted treatment tailored to each individual patient's clinical and genetic profile, thus improving treatment efficacy and patient prognosis